Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020
Clinical trial NCT04352751 · UNKNOWN
Trial details
- NCT number
- NCT04352751
- Sponsor
- Hilton Pharma
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2021-04-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.